Alexandra G. Fraga graduated in 2003 in Applied Biology and in 2010 recieved a PhD in Health Sciences from the Univeristy of Minho (UM). Bewteen 2011 and 2019 she developed her postdoctoral studies at the Microbiology and Infection Research Domain at the Life and Health Sciences Research Institute (ICVS), during which she focused on studying the spontaneous healing process of experimental Buruli ulcer, using RNA-Sequencing in animal models of resistance (guinea pigs) and susceptibility (mice) to Mycobacterium ulcerans infection. From 2019 and 2021, she was a junior researcher and her research focused on the identification of the regulatory effects of interindividual genetic variations on molecular and cellular processes of mycobacterial immunity, as well as on the modulation of the host immune response/bacterial activity by using new systems of antimicrobial drug delivery. She is currently continuing this line of research as an Assitant Researcher at the InflammaSignal team at the ICVS. She is recently an Assistant Professor at the School of Medicine, UM. Her track record includes 40 peer-reviewed research articles and 2 book chapters, with an h-index of 19, an accumulated IF of ~200 and over 1500 citations. She has been supported by several funding agencies (e.g., InfectERA, la Caixa Foundation, FCT, ESCMID) and contracts with the industry (e.g., Amicus Therapeutics). She has successfully concluded the supervision of 2 PhD and 5 MSc students. She is the Biosafety Coordinator at the ICVS and is the ICVS representative in the Portuguese Biosafety Laboratory Network, Lab-PTBioNet. She has FELASA Category C accreditation for animal experimentation by the Portuguese National Authority for Animal Health (DGAV) and a vast experience in the mouse and guinea pig model of infection under BSL2 and BSL3 conditions.